Pluristem Stock Probability Of Bankruptcy

PSTI Stock  ILS 2,010  13.00  0.65%   
Pluristem's likelihood of distress is under 38% at this time. It has slight risk of undergoing some form of financial straits in the near future. Chance of distress shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Pluristem balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pluristem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
  

Pluristem Company chance of distress Analysis

Pluristem's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Pluristem Probability Of Bankruptcy

    
  Less than 38%  
Most of Pluristem's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pluristem is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Pluristem probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Pluristem odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Pluristem financial health.
Please note, there is a significant difference between Pluristem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pluristem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pluristem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Pluristem has a Probability Of Bankruptcy of 38.0%. This is 12.22% lower than that of the Healthcare sector and 30.71% lower than that of the Biotechnology industry. The probability of bankruptcy for all Israel stocks is 4.59% higher than that of the company.

Pluristem Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pluristem's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pluristem could also be used in its relative valuation, which is a method of valuing Pluristem by comparing valuation metrics of similar companies.
Pluristem is currently under evaluation in probability of bankruptcy category among its peers.

Pluristem Fundamentals

About Pluristem Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pluristem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pluristem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pluristem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Pluristem Stock

Pluristem financial ratios help investors to determine whether Pluristem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pluristem with respect to the benefits of owning Pluristem security.